Epigral Limited — Others, 27-03-2025: Trading Window

Epigral Limited has announced a closure of the trading window for all insiders, directors, promoters, and designated persons from 1st April 2025 until 48 hours after the release of its audited financial results for the fourth quarter and year ending 31st March 2025. The date for the board meeting to approve these results will be revealed later. This move aims to maintain compliance with insider trading regulations. Investors should note the closure could create a temporary pause in trading, but the upcoming results may present opportunities for market movement based on financial performance.